ACOR - Acorda Therapeutics EPS beats by $0.26 beats on revenue February, 13 2020 07:09 AM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR): Q4 Non-GAAP EPS of -$0.15 beats by $0.26; GAAP EPS of $1.38 beats by $2.33.More news on: Acorda Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...